RNAi modulation of ApoB and uses thereof

Details for Australian Patent Application No. 2005289588 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Vornlocher, Hans-Peter; Elbashir, Sayda; Soutschek, Juergen; Hadwiger, Philipp

Agent Griffith Hack

Pub. Number AU-B-2005289588

PCT Pub. Number WO2006/036916

Priority 60/613,141 24.09.04 US

Filing date 26 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 22 December 2011

International Classifications

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/036916 Priority application(s): WO2006/036916

22 December 2011 Application Accepted

  Published as AU-B-2005289588

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289591-Treatment of neurological deficits in the striatum or substanta nigra pars compacta

2005289578-System and method for distributing software licenses